WSFS
UTHR icon

Wilmington Savings Fund Society’s United Therapeutics UTHR Stock Holding History

Wilmington Savings Fund Society’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39
Closed -$11.2K – 2033
2025
Q2 		$11.2K Hold
39
– – ﹤0.01% 1605
2025
Q1 		$12K Hold
39
– – ﹤0.01% 1594
2024
Q4 		$13.8K Hold
39
– – ﹤0.01% 1583
2024
Q3 		$14K Buy
+39
New +$13.2K ﹤0.01% 1560
2016
Q2 		– Sell
-1,974
Closed -$220K – 352
2016
Q1 		$220K Buy
1,974
+35
+2% +$4.43K 0.01% 316
2015
Q4 		$304K Buy
1,939
+414
+27% +$60.3K 0.02% 280
2015
Q3 		$200K Buy
+1,525
New +$245K 0.01% 335

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wilmington Savings Fund Society's UTHR Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 39 shares — an estimated $11.2K sold.

Wilmington Savings Fund Society first reported a position in UTHR in Q3 2015 and held it in 7 quarters. The position peaked at $304K in Q4 2015. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 39 United Therapeutics shares in Q3 2025, an estimated $11.2K.
  • Wilmington Savings Fund Society first reported a position in United Therapeutics in Q3 2015 and held it in 7 quarters.
  • Wilmington Savings Fund Society's United Therapeutics position peaked at $304K in Q4 2015.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.